Good Lifestyle

The Delta variant has raised new concerns for people in the United States - even those who arefully vaccinated. Vaccine societies are blurred to find a solution and many Americans are impatient from another dose. But with the variant of Delta overlooking the country, there is a debate on whether it would be preferable to obtain a third dose of an existing vaccine or to wait for something specifically designed to protect this very infectious iteration of the virus. Now, Pfizer revealed how long it would take to get a delta variant vaccine booster.

RELATED:If you have Pfizer, this new study is a "clock call", says Biden help.

On August 11, Pfizer told Axios that the company expects to "be able to develop and produce a tailor-made vaccine against this variantIn about 100 days After a decision to do so, subject to the approval of the regulations. "This comment comes after a new pre-imprint study that found that the current effectiveness of the Pfizer vaccine falls significantly in the fight against the Delta variant.

The study, conducted by NFRECE and the Mayo Clinic and published in Medrxiv on August 8, found that the Pfizer Covid Vaccine wasonly 42% effective Against the virus in July when Delta was the dominant variant. This is a dramatic drop in protection against the efficacy of 95% vaccines in clinical trials. The study also found that the effectiveness of the Moderna vaccine fell to 76% in July, although the data showed that the protection of vaccines against a serious illness was not considerably diminished against the delta variant.

RELATED:For more information up to date, sign up for our daily newsletter.

So, what does it mean so that people hope to protect their protection? On July 28, Pfizer shared data showing a third dose of his vaccine could considerablystrengthen the protection Beyond what the standard two dose plan currently offers. This reminder shot would not be specifically formulated to combat the delta, but the extra dose could always be effective.

Meanwhile, the July 28th report of Pfizer revealed that the first batch of a Delta variant vaccine was manufactured and clinical studies should start one day in August, subject to regulatory approvals. August 9,Fortune reported that the Pfizer's partnerBiontech plans to start testing A modified form of the Covid vaccine to see if it can help provide stronger protection against the Delta variant, the results of this clinical trial should arrive in the fourth quarter.

The other company that has developed a CMNA vaccine against Covid is also in the process ofboost. June 8, during the Health Summit of Forbes Health, CEO of ModernaStéphane BantelTolds that current Covid vaccines are probably enough to protect people in the long run as a result of emerging variants. He predicted to predict that the rapprochement shots of Moderna would start to embark on arms in the fall or winter, noting that it is better to be "two months too early than two months too late "

RELATED:Pfizer has just said that "strongly" reinforces the protection of the delta variant.